BABY GREENLIN COUGH LINCTUS

This brand name is authorized in Nigeria.

Active ingredients

The drug BABY GREENLIN COUGH LINCTUS contains one active pharmaceutical ingredient (API):

`1`	Dilute acetic acid UNII `Q40Q9N063P` - ACETIC ACID
	Acetic acid is indicated for the treatment of superficial infections of the external auditory canal.
	Read more about Acetic acid

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
M01AB	Acetic acid derivatives and related substances	M Musculo-skeletal system → M01 Antiinflammatory and antirheumatic products → M01A Antiinflammatory and antirheumatic products, non-steroids
Discover more medicines within M01AB

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
NG	Registered Drug Product Database	A4-1079
Switch country to Nigeria in order to find specific presentations of BABY GREENLIN COUGH LINCTUS

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.